2025-11-13T12:13:50-06:00 2024-12-31 521738520 LANE & COMPANY CPAS 5335 WISCONSIN AVE NW WASHINGTON DC 20015 990 2024-01-01 830397854 KING HUSSEIN CANCER FOUNDATION USA KING 9175920901 601 MASSACHUSETTS AVE NW 7403B WASHINGTON DC 20001 LEILA LARIJANI TREASURER 9175920901 2025-11-13 1 1 ROBERT E LANE P01622353 2026172615 2025-11-13 X 2024 2025-03-06 01:10:19Z YOLANDA GASALLA 601 MASSACHUSETTS AVE NW 7403B WASHINGTON DC 20001 2584317 0 X WWW.KHCFUSA.ORG X 2004 DC KHCF USA FURTHERS THE MISSION OF THE KING HUSSEIN CANCER FOUNDATION IN JORDAN AND THE ADVANCEMENT OF CANCER RESEARCH BY PROMOTING AND PROVIDING EDUCATIONAL MATERIALS AND ENGAGING IN FUNDRAISING TO SUPPORT THE FOUNDATION IN JORDAN. 12 12 0 12 0 0 1173679 2503149 0 0 53680 81168 0 0 1227359 2584317 853233 2261521 0 0 0 0 0 0 0 21479 22156 874712 2283677 352647 300640 1093877 1394419 0 0 1093877 1394419 KHCF USA FURTHERS THE MISSION OF THE KING HUSSEIN CANCER FOUNDATION IN JORDAN AND THE ADVANCEMENT OF CANCER RESEARCH BY PROMOTING AND PROVIDING EDUCATIONAL MATERIALS AND ENGAGING IN FUNDRAISING TO SUPPORT THE FOUNDATION IN JORDAN. 0 0 2261521 2261521 THE ORGANIZATION PROVIDED GRANTS FOR CANCER RESEARCH, TREATMENT, AND OTHER CHARITABLE PURPOSES AT THE KING HUSSEIN CANCER CENTER IN JORDAN. 2261521 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 1 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 1 2 0 1 0 0 0 0 0 0 0 0 0 0 0 0 0 X 12 12 0 0 0 0 0 0 0 1 1 0 0 1 1 1 1 0 0 0 0 0 X LEILA LARIJANI 9175920901 601 MASSACHUSETTS AVE NW STE 7403B WASHINGTON DC 20001 X YOLANDA GASALLA PRESIDENT 1.00 X X 0 0 0 HRH PRINCESS GHIDA TALAL VICE PRESIDENT 1.00 X X 0 0 0 LEILY BATMANGHELIDJ SECRETARY 1.00 X X 0 0 0 LEILA LARIJANI TREASURER 1.00 X X 0 0 0 GHIDA AL-JUBURI DIRECTOR 1.00 X 0 0 0 AMIRA SALAAM AMRO DIRECTOR 1.00 X 0 0 0 FAWAZ BILBEISI DIRECTOR 1.00 X 0 0 0 SAMIA FAROUKI DIRECTOR 1.00 X 0 0 0 NISREEN QATAMISH DIRECTOR 1.00 X 0 0 0 ALIYYA STUDE DIRECTOR 1.00 X 0 0 0 CLAUDE WASSERSTEIN DIRECTOR 1.00 X 0 0 0 ELEANOR WEHLEN DIRECTOR 1.00 X 0 0 0 0 0 0 0 0 0 0 0 359980 2143169 2503149 81168 81168 2584317 0 0 81168 2261521 2261521 5571 5571 6150 6150 9410 9410 1025 1025 2283677 2261521 22156 0 1093877 1394419 1093877 1394419 0 0 X 1093877 1394419 1093877 1394419 1093877 1394419 300640 -98 0 X 0 0 0 X 753257 497382 601749 1173679 2503149 5529216 753257 497382 601749 1173679 2503149 5529216 1970333 3558883 1270 0 6238 53680 81168 142356 5671572 0.62750 0.57350 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 1 MIDDLE EAST 0 0 GRANTS TO RECIPIENT 2261521 0 0 0 0 0 0 2261521 0 2261521 MIDDLE EAST CANCER TREATEMENT 2261521 WIRE 0 1 0 0 0 0 0 0 PART I, LINE 2: THE BOARD RECEIVES AND REVIEWS DETAILED REPORTS THAT DESCRIBE THE ACTIVITIES AND EXPENDITURES SUPPORTED BY THE GRANTS. FORM 990, PART VI, SECTION B, LINE 11B A COPY IS EMAILED TO EACH OF THE BOARD MEMBERS. THE TREASURER REVIEWS THE 990 INDEPENDENTLY WITH THE CORPORATION'S LEGAL COUNSEL. FORM 990, PART VI, SECTION B, LINE 12C THE CORPORATION'S POLICY IS WRITTEN TO PROTECT THE CORPORATION'S INTEREST WHEN IT IS CONTEMPLATING ENTERING INTO A TRANSACTION OR ARRANGEMENT THAT MIGHT BENEFIT THE PRIVATE INTEREST OF THE CORPORATION'S DIRECTORS, OFFICERS, OR COMMITTEE MEMBERS. IN CONNECTION WITH ANY POSSIBLE CONFLICTS OF INTEREST, AN INTERESTED PERSON MUST DISCLOSE THE EXISTENCE OF HIS OR HER INTEREST AND ALL MATERIAL FACTS TO THE DIRECTORS CONSIDERING THE PROPOSED TRANSACTION OR AGREEMENT. AFTER DISCLOSURE OF ALL MATERIAL FACTS AND DISCUSSION WITH THE PERSON, THE PERSON SHALL LEAVE THE BOARD MEETING WHILE THE DETERMINATION OF A CONFLICT OF INTEREST IS DISCUSSED AND VOTED UPON. THE REMAINING BOARD MEMBERS SHALL DECIDE IF A CONFLICT OF INTEREST EXISTS. IF THE BOARD MEMBERS FIND THAT A CONFLICT OF INTEREST EXISTS, THE BOARD MEMBERS SHALL DETERMINE WHETHER THE CORPORATION CAN OBTAIN A MORE ADVANTAGEOUS TRANSACTION OR AGREEMENT WITH REASONABLE EFFORTS THAT WOULD NOT GIVE RISE TO A CONFLICT OF INTEREST. FORM 990, PART VI, SECTION C, LINE 19 KING HUSSEIN CANCER FOUNDATION USA MAKES ITS GOVERNING DOCUMENTS, CONFLICT OF INTEREST POLICY, AND FINANCIAL STATEMENTS AVAILABLE UPON REQUEST.